Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.050
+0.040 (1.99%)
At close: Jun 2, 2025, 4:00 PM
2.040
-0.010 (-0.49%)
After-hours: Jun 2, 2025, 4:38 PM EDT

Inhibikase Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-36.55-27.52-19.03-18.05-14.79-2.85
Upgrade
Depreciation & Amortization
0.030.030.180.01--
Upgrade
Stock-Based Compensation
10.138.140.50.461.530.57
Upgrade
Other Operating Activities
-1.16-0.030.070.721.61
Upgrade
Change in Accounts Receivable
--0.040.07-0.11-
Upgrade
Change in Accounts Payable
0.470.27-0.50.06-0.63-0.25
Upgrade
Change in Unearned Revenue
-----2.330.9
Upgrade
Change in Other Net Operating Assets
0.34-0.070.70.041.3-1.11
Upgrade
Operating Cash Flow
-19.38-19.15-18.09-17.35-14.3-1.13
Upgrade
Capital Expenditures
-0.01--0.01-0.24--
Upgrade
Investment in Securities
-12.19-3711.67-15.76--
Upgrade
Investing Cash Flow
-12.64-3711.66-16.01--
Upgrade
Long-Term Debt Issued
-----0.27
Upgrade
Total Debt Issued
-----0.27
Upgrade
Long-Term Debt Repaid
----0.25-0.04-
Upgrade
Total Debt Repaid
----0.25-0.04-
Upgrade
Net Debt Issued (Repaid)
----0.25-0.040.27
Upgrade
Issuance of Common Stock
103.08103.488.540.0441.2114.79
Upgrade
Repurchase of Common Stock
-----0.08-
Upgrade
Other Financing Activities
0.03--0.14---
Upgrade
Financing Cash Flow
103.11103.488.41-0.241.0915.06
Upgrade
Net Cash Flow
71.0947.331.98-33.5626.813.94
Upgrade
Free Cash Flow
-19.4-19.15-18.1-17.59-14.3-1.13
Upgrade
Free Cash Flow Margin
---6947.87%-14253.37%-461.10%-161.69%
Upgrade
Free Cash Flow Per Share
-0.44-0.81-3.00-4.17-4.71-0.82
Upgrade
Cash Interest Paid
---000.01
Upgrade
Levered Free Cash Flow
-10.27-8.93-12.17-10.97-9.47-1.49
Upgrade
Unlevered Free Cash Flow
-10.27-8.93-12.17-10.97-9.46-1.48
Upgrade
Change in Net Working Capital
-4.75-0.770.28-0.141.760.29
Upgrade
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q